Inspire Medical Systems, Inc. to Report First Quarter 2021 Financial Results on May 4, 2021
Inspire Medical Systems (NYSE: INSP) will release its first quarter 2021 financial results on May 4, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) will release its first quarter 2021 financial results on May 4, 2021, after market close. A conference call will follow at 5:00 p.m. Eastern Time for management to discuss results and recent developments. Inspire focuses on innovative solutions for obstructive sleep apnea and offers the only FDA-approved neurostimulation therapy for this condition. For further information, visit www.inspiresleep.com.
Positive
- Inspire offers the first FDA-approved neurostimulation technology for obstructive sleep apnea.
Negative
- None.
Details
News Market Reaction – INSP
The recorded move for INSP in the trading session of this news was +1.06%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, April 06, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the first quarter 2021 after the close of trading on Tuesday, May 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
| Tuesday, May 4th @ 5:00 p.m. Eastern Time: | ||
| Domestic: | 877-407-0792 | |
| International: | 201-689-8263 | |
| Conference ID: | 13717525 | |
| Webcast: | http://public.viavid.com/index.php?id=143909 | |
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact:
Bob Yedid
LifeSci Advisors
inspire@lifesciadvisors.com
646-597-6989
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.